Epidemiological trends of TB in Eastern Europe TB and migration
|
|
- Joanna Barton
- 5 years ago
- Views:
Transcription
1 KOCH-METSCHNIKOW-FORUM МEЧНИКОВ-КОХ-ФОРУМ XX Congreso Internacional sobre Tuberculosis UITB-216 November 21 and 22, 216 Epidemiological trends of TB in Eastern Europe TB and migration Timo Ulrichs Koch-Metschnikow-Forum, Vice President and Head of the Tuberculosis Section; Akkon University for Human Sciences Tuberculosis in Germany 1
2 Tuberculosis in Germany (Ref.: From a talk by Robert Koch, Sitzung der Akademie der Wissenschaften zu Berlin am 7. April 191) Tuberculosis in Germany Erkrankungen/1. Einwohner ,4 1,4 9,2 9,3 2,7 2,3 9,8 8,7 2,4 8,9 7,9 2,2 8,2 7,3 2, 7,3 6,5 1,7 6,8 6,1 1,6 6,2 6,1 5,8 5,5 5,4 5,3 1,5 1,1 1,3 Gesamt Erwachsene Kinder Meldejahr * Ref.: Robert Koch Institute 2
3 TB burden in the WHO European Region, new cases and 46 deaths 49 new cases and 7 deaths every hour Global TB control report, 21 TB burden in the WHO European Region, estimated, 33 notified* (5.6% of the global burden in 29) 46 deaths due to TB Majority of TB patients (87%) and deaths (92%) were from the 18 high priority countries (HPC) of the Region. Highest case detection rate (78%) and lowest treatment success rate (7%) among all the Regions TB risk factors in Europe HIV: 6 15% Smoking: 21 29% Diabetes: 14 15% Alcohol: 14 35% Global TB control report, 21, TB surveillance in Europe, report 29 3
4 Even with the fastest decline in TB incidence in the world, nearly 1 Europeans fall ill every day New TB cases estimated to occur per year: 34. Estimated total number of TB patients in the Region: over 44. Since 25, new TB cases have been falling at an average rate of 5.2% per year WHO European Region has fastest decline of TB incidence in the world TB notification trend reflects true reduction in spread of the disease and is strongly influenced by improvements in high-priority countries. 9 WHO European Region, Rate per 1 population ,9 37 3,5 12,2 Notification (18 High-priority countries) Estimated incidence (53 Member States) Notification rate (53 Member States) Notification (European Union/European Economic Area (EU/EEA)) Source: European Centre for Disease Prevention and Control / WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 216. Stockholm: European Centre for Disease Prevention and Control; 216 4
5 Less wealthy countries are the most affected More TB Estimated TB incidence rate per 1, population TB incidence rate, GDP per capita and estimated new and relapses caseload in 53 MSs of WHO European Region, MDA 16 KGZ TJK UKR GEO AZE LTU 6 UZB BIH BLR TKM LVA 4 IRL ARM SRB BGR TUR POL PRT EST DEU ESP FRA GBR 2 MLT SVK CZE SVN ITA CYP ISRANDFIN NLDDNK CHE MNE GRC NOR ISL MKD HRV HUN AUT BEL SWE Gross Domestic Product per capita (current US$, 214) ROU RUS KAZ More wealth TB burden is unequally distributed 83% of incident TB cases 92% of TB deaths 99.5% of MDR-TB cases 88% of TB/HIV coinfections occur in the 18 high-priority countries in the Region Estimated TB incidence per 1 population, WHO European Region, 214 Source: European Centre for Disease Prevention and Control/WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 216. Stockholm: European Centre for Disease Prevention and Control; high-priority countries: Armenia, Azerbaijan, Belarus, Bulgaria, Estonia, Georgia, Kazakhstan, Kyrgyzstan, Latvia, Lithuania, Republic of Moldova, Romania, Russian Federation, Tajikistan, Turkey, Turkmenistan, Ukraine, Uzbekistan. 5
6 The transmission of MDR-TB is continuing Source: European Centre for Disease Prevention and Control/WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 216. Stockholm: European Centre for Disease Prevention and Control; 216. MDR-TB detection and treatment have much improved since the start of the MDR-TB Action Plan Baseline before the endorsement of MAP Achievements during period of MAP implementation 6
7 TB notification by origin, EU/EEA, Under-detection of TB among children remains a challenge in the WHO European Region Adults Detected 32% Undetected 15% 1 85% % Children 9% of all new TB cases in 214 were children Whereas most cases among adults are detected, the contrary happens for children 7
8 HIV co-infection among TB patients continues to rise in the WHO European Region Proportion of HIV co-infection among TB patients in WHO European Region, HIV and TB create a deadly synergy 9 8 7,8 8, Between 26 and 214 HIV- TB co-infection increased from 2.8% to 8.% with annual average increase of 13% % HIV among TB cases ,8 2,8 3,4 4,8 6, 6,3 6, Source: European Centre for Disease Prevention and Control/WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 216. Stockholm: European Centre for Disease Prevention and Control; 216. Effectiveness of TB treatment remains one of the biggest challenges for the WHO European Region Only 3 in 4 newly registered TB patients notified in the region is successfully treated % Treatment success rate of all new and relapse, WHO Regions, 199 and AFR AMR EMR EUR SEAR WPR Global
9 Effectiveness of TB treatment remains one of the biggest challenges for the WHO European Region 1 8 % 6 Treatment success rate of all new and relapse, WHO Regions, 199 and AFR AMR EMR EUR SEAR WPR Global Only 1 in 2 patients with MDR-TB or HIV co-infection has the chance of being cured For patients with XDR TB the chance of cure is below 3% TB treatment is even more challenging among previously treated, HIV co-infected and M/XDR-TB patients Comparison of treatment outcome of TB patients by history, HIV status and drug resistance, WHO European Region 6, 7,2 5,8 5,2 13,1 7,1 11, 75,8 11, 57,7 4,1 7,4 2,9 2,8 46,7 8, 13,5 16,4 13,4 48,7 11,6 12,9 24,1 24,1 27,4 New&relapse Retreated HIV positive RR/MDR XDR Success Died Failed Lost to follow-up Not evaluated 9
10 TB Action Plan for the WHO European Region, Vision: An end to the TB epidemic Goal: To stop the spread of drugsusceptible and drug-resistant TB by achieving universal access to prevention, diagnosis and treatment in all Member States of the WHO European Region. Targets: 35% reduction in TB deaths 25% reduction in TB incidence rate 75% treatment success rate among the MDR-TB patient cohort To reach targets we need to: Scale-up rapid diagnosis Expand patient-centred care Introduce shorter and more effective treatment regimens including new medicines Expand preventive therapy and research for new tools Boost intersectoral approach to address inequities TB control challenges in the WHO European Region Economic recession, poverty and socially vulnerable groups (homeless, unemployed, alcohol-dependent) Health systems: poorly developed or under reform, leading to ineffective TB control M/XDR-TB: the highest rates in the world in EUR HIV epidemic: growing (mainly through injecting drugs users) TB in prisons: penitentiary system very large with poor TB services Migration (East to West, South to North, internal migration) 1
11 Koch-Metschnikov-Forum Contact: Timo Ulrichs Head of Section Tuberculosis 11
TB/HIV in the WHO European Region Overview, Priorities & Response
TB/HIV in the WHO European Region Overview, Priorities & Response 16 th Core Group Meeting TB/HIV Working Group Stop TB Partnership Almaty, Kazakhstan May 2010 Martin Donoghoe Andrei Dadu, Smiljka de Lussigny
More informationProgress on the targets of Millennium Development Goal 6 in central and eastern Europe and central Asia
Progress on the targets of Millennium Development Goal 6 in central and eastern Europe and central Asia 11 October 2011 Moscow, Russian Federation Zsuzsanna Jakab WHO Regional Director for Europe Millennium
More informationNutrition, diet and health in the WHO European Region Progress and opportunities for further action to achieve SDGs by 2030
Nutrition, diet and health in the WHO European Region Progress and opportunities for further action to achieve SDGs by 2030 João Breda Head, WHO European Office for Prevention and Control of Noncommunicable
More informationAssessment of PM2.5 concentrations
Assessment of PM2.5 concentrations and health impacts at a European level 14 th EIONET workshop on air quality assessment and management Warsaw 5-6 October 29 Frank de Leeuw, Jan Horálek PM2.5 monitoring
More informationName of the presenter
Progress in tuberculosis care: setting the scene for Central Asia Name of the presenter Gombogaram Tsogt, Shalva Gamtsemlidze Quality Health Care Project Global TB estimates All forms of TB greatest number
More informationUNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA DOCTORAL THESIS ABSTRACT
UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA DOCTORAL THESIS ABSTRACT Epidemiological aspects of tuberculosis disease in disadvantaged population groups in Dolj county in the period 2006-2011 PhD Supervisor,
More informationChildhood TB and new TB drugs in the WHO European Region
Andrei Dadu Carl Cordonnier Maxim Dondiuk Childhood TB and new TB drugs in the WHO European Region Kigali, Rwanda, 09/10/ 2017 Dr Martin van den Boom, MD, MSc PH, WHO Regional Office for Europe, Joint
More informationMENTAL HEALTH CARE. OECD HCQI Expert meeting 17 th of May, Rie Fujisawa
MENTAL HEALTH CARE OECD HCQI Expert meeting 17 th of May, 2013 Rie Fujisawa Mental health indicators Any hospital readmissions for patients with schizophrenia Same hospital readmissions for patients with
More informationReflecting on ten years of progress in the fight against AIDS, TB and malaria
Reflecting on ten years of progress in the fight against AIDS, TB and malaria Michel Kazatchkine UN Secretary General s Special Envoy on HIV/AIDS in Eastern Europe and central Asia Ten years of progress:
More informationThe WHO Global Project on anti-tb drug resistance surveillance: background, objectives, achievements, challenges, next steps
The WHO Global Project on anti-tb drug resistance surveillance: background, objectives, achievements, challenges, next steps Matteo Zignol STOP TB Department World Health Organization TB surveillance and
More informationHealthy Cities: From Strategy to Implementation
Healthy Cities: From Strategy to Implementation Susanna Kugelberg PhD MSc Consultant, Nutrition, Obesity and Physical Activity Programme, Division of Non-Communicable Disease and Lifecourse WHO/Europe
More informationTuberculosis surveillance in Germany. Data of the tuberculosis report 2013
1 Tuberculosis surveillance in Germany Data of the tuberculosis report 2013 Robert Koch Institute (RKI) Respiratory Infections Unit Outline 2 Tuberculosis notification system in Germany Epidemiological
More information4/25/2012. The information on patterns of infection and disease can assist in: Assessing current and evolving trends in TB
Sindy M. Paul, MD, MPH, FACPM May 1, 2012 The information on patterns of infection and disease can assist in: Assessing current and evolving trends in TB morbidity, including resistance Identifying people
More informationThe epidemiology of tuberculosis
The epidemiology of tuberculosis Tuberculosis Workshop Shanghai, 12-22 May 28 Philippe Glaziou World Health Organization Outline Epidemiology refresher Estimates of tuberculosis disease burden Notifications
More informationMDR-TB and HIV co-infection in Eastern Europe. Francis Drobniewski MBBS PhD Professor of Global Health and Tuberculosis
MDR-TB and HIV co-infection in Eastern Europe Francis Drobniewski MBBS PhD Professor of Global Health and Tuberculosis f.drobniewski@imperial.ac.uk Conflict of interest In the last year I have been a consultant
More informationXDR TUBERCULOSIS IN EUROPE EPIDEMIOLOGICAL ASPECTS. Enrico Girardi Unità di Epidemiologia Clinica INMI Spallanzani, Roma. Pag. 1
XDR TUBERCULOSIS IN EUROPE EPIDEMIOLOGICAL ASPECTS Enrico Girardi Unità di Epidemiologia Clinica INMI Spallanzani, Roma Pag. 1 TB estimated incidence in EUR, 2004 Russian Fed. 12 th among the 22 TB high-burden
More informationDeveloping a structured obesity and nutrition training programme for primary care
753 CASE STUDY Developing a structured obesity and nutrition training programme for primary care Rachel Pryke¹ 1 Winyates Health Centre, Redditch, United Kingdom Corresponding author: Rachel Pryke (email:
More informationGAVI in the WHO European Region: results, current status and future
Strengthening immunization services and introduction of hepatitis B vaccine in countries of Central and Eastern Europe and Newly Independent States, 3 rd meeting, Кiev, 25-28 May 2004 GAVI in the WHO European
More informationKey issues for HIV testing and
Key issues for HIV testing and counselling in Europe Martin C Donoghoe Programme Manager HIV/AIDS, STI &Viral Hepatitis Programme WHO Europe Key issues for HIV testing & counselling in Europe HIV epidemics
More informationCombating HIV/AIDS and TB in Eastern Europe and Central Asia: The World Bank Response
Combating HIV/AIDS and TB in Eastern Europe and Central Asia: The World Bank Response Paolo Carlo Belli, Country Sector Coordinator, Human Development ECA Region May 13, 2011 November 28, 2007 ECA AIDS
More informationMeasuring TB burden and access to TB services for people who inject drugs in the WHO European Region, 2010 and 2011
Measuring TB burden and access to TB services for people who inject drugs in the WHO European Region, 2010 and 2011 Annabel Baddeley Global TB Programme WHO, Geneva Outline of presentation Global and European
More informationReport on the work of the WHO Regional Office for Europe
68TH SESSION OF THE WHO REGIONAL COMMITTEE FOR EUROPE Rome, Italy, 17 20 September 2018 Report on the work of the WHO Regional Office for Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe Better
More informationWhat can be done against XDR-TB?
What can be done against XDR-TB? Dr Matteo Zignol Stop TB Dep. World Health Organization Geneva 16 th Swiss Symposium on tuberculosis Münchenwiler, 22 March 2007 XDR-TB Extensive Drug Resistance XDR =
More informationEpidemiology of tuberculosis in Europe. Marieke J. van der Werf European Centre for Disease Prevention and Control Amsterdam, 22 September 2014
Epidemiology of tuberculosis in Europe Marieke J. van der Werf European Centre for Disease Prevention and Control Amsterdam, 22 September 2014 Tuberculosis surveillance in the EU Aim: To provide a complete
More informationWorld Health Organization 2013
World Health Organization 2013 All rights reserved. Publications of the World Health Organization are available on the WHO web site (www.who.int) or can be purchased from WHO Press, World Health Organization,
More informationUsing Data For Decision Making
Using Data For Decision Making Juliana Víctor-Ahuchogu World Bank Acknowledgment and data sources AIDS in the Commonwealth of Independent States: AIDS 2008 MAP Report: Magomed Nashkhoev & Boris Sergeyev,
More informationThe WHO END-TB Strategy
ENDING TB and MDR-TB The WHO END-TB Strategy Dr Mario RAVIGLIONE Director Joint GDI/GLI Partners Forum WHO Geneva, 27 April 2015 This talk will deal with TB Burden Progress, Challenges Way Forward Who
More informationIntroduction to the Global AMR Action Plan
Introduction to the Global AMR Action Plan Dr Danilo Lo Fo Wong Programme Manager Antimicrobial Resistance Antibiotic resistance WHO meetings, consultations, workshops in 1971, 1977, 1981, 1982, 1994,
More informationAlcohol-related harm in Europe and the WHO policy response
Alcohol-related harm in Europe and the WHO policy response Lars Moller Programme Manager World Health Organization Regional Office for Europe Date of presentation NCD global monitoring framework: alcohol-related
More informationStop TB Working Group on DOTS-Plus for MDR-TB Strategic Plan
Stop TB Working Group on DOTS-Plus for MDR-TB Strategic Plan 2006-2015 Background Current threat and status of the global epidemic of multidrug resistant tuberculosis (MDR-TB) Along with HIV/AIDS, MDR-TB
More informationThe cancer burden in the European Union and the European Region: the current situation and a way forward
The cancer burden in the European Union and the European Region: the current situation and a way forward Presented by Zsuzsanna Jakab WHO Regional Director for Europe Informal Meeting of Health Ministers
More informationParadoxes of well-being
Paradoxes of well-being Latin American Conference on Measuring Well- Being and Fostering the Progress of Societies Marco Mira d Ercole OECD Statistics Directorate Mexico City, 11-13 May 2011 Content of
More informationEuropean status report on alcohol and health Leadership, awareness and commitment
European status report on alcohol and health 2014 Leadership, awareness and commitment Leadership, awareness and commitment Background Strong leadership from national and local governments is essential
More informationDrug-resistant Tuberculosis
page 1/6 Scientific Facts on Drug-resistant Tuberculosis Source document: WHO (2008) Summary & Details: GreenFacts Context - Tuberculosis (TB) is an infectious disease that affects a growing number of
More informationTurning the Tide Against HIV and Tuberculosis. Global Fund Investment Guidance for Eastern Europe and Central Asia
Turning the Tide Against HIV and Tuberculosis Global Fund Investment Guidance for Eastern Europe and Central Asia Acknowledgement In order to ensure that the views of a variety of stakeholders were represented
More informationMay 26-28, 2010, Almaty, Kazakhstan November 2011
Progress note of the recommendations of the 16 th TB/HIV Core Group Meeting Report May 26-28, 2010, Almaty, Kazakhstan November 2011 1. Structural and organizational barriers The Core Group urges Ministries
More informationWorld Health Organization Regional Office for Europe Surveillance of measles and rubella Data as of 15 March 2006
World Health Organization Regional Office for Europe Surveillance of measles and rubella Data as of 15 March 2006 WHO Regional Office for Europe Vaccine-preventable Diseases and Immunization programme,
More informationFact sheets on sustainable development goals: health targets. Malaria
SDG target 3.3: by 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, waterborne diseases and other communicable diseases. Fact sheets on sustainable
More informationTB surveillance. Philippe Glaziou Dubrovnik, May 2009
TB surveillance Philippe Glaziou Dubrovnik, May 2009 What are the global TB targets? Outcome targets (World Health Assembly, STB Partnership) Case detection ratio > 70% Treatment success > 85% 2015 Impact
More informationInformation about activities in the region of possible relevance for the regional strategic plan. GF-TADs for Europe
First Task-Force meeting Belgrade /Serbia 20-21 December 2016 Information about activities in the region of possible relevance for the regional strategic plan GF-TADs for Europe N. Leboucq Secretariat
More informationSituation update in the European Region: overview of influenza surveillance data week 40/2009 to week 07/2010.
Situation update in the European Region: overview of influenza surveillance data week 40/2009 to week 07/2010. WHO/Europe publishes a weekly electronic bulletin on influenza activity in the Region 1 and
More informationTuberculosis action plan for the WHO European Region REGIONAL COMMITTEE FOR EUROPE 65th SESSION. Working document
REGIONAL COMMITTEE FOR EUROPE 65th SESSION Vilnius, Lithuania, 14 17 September 2015 Carl Cordonnier Tuberculosis action plan for the WHO European Region 2016 2020 Working document Regional Committee for
More information#4 (Tuberculosis OR TB OR Pulmonary Tuberculosis OR Multi-Drug Resistant Tuberculosis OR MDR OR Extremely-Drug Resistant Tuberculosis or XDR)
DATABASE Cochrane Database of Systematic Reviews DATE 15 DECEMBER 2015 #1 Safety of Crucell Ad35/ AERAS-402 OR Effectiveness of Crucell Ad35/ Aeras-402 OR Safety of MVA85A/ Aeras-485 OR Effectiveness of
More informationChanges in Subjective Well-Being and Their Implications
Changes in Subjective Well-Being and Their Implications Hae-sik Jung Associate Research Fellow, KIHASA Sunhee Woo Senior Researcher, KIHASA Introduction Since subjective well-being emerged as a policy
More informationThe Global Fund s view on transition Dumitru Laticevschi The Global Fund
Treating Patient, Not Disease: People-Centered Approach 7th TB Symposium Ministry of Health of the Kyrgyz Republic and Médecins Sans Frontières 1-2 March, 2018, BISHKEK, KYRGYZSTAN The Global Fund s view
More informationRegional Committee for Europe Fifty-second session
Regional Committee for Europe Fifty-second session Copenhagen, 16 19 September 2002 Provisional agenda item 7(b) EUR/RC52/9 Add.1 18 July 2002 23012 ORIGINAL: ENGLISH DOTS EXPANSION PLAN TO STOP TB IN
More informationHepatitis C No Barriers to Cure
2018 Digestive Diseases Conference Kansas Hepatitis C No Barriers to Cure Dr. Mauricio Lisker Melman Professor of Medicine Director Hepatology Program Division of Gastroenterology Disclosure The following
More informationBetter Health for All in Latvia
Better Health for All in Latvia The health strategy for the European Region (Health 2020) and the Latvian Public Health Strategy 2011 2017 Zsuzsanna Jakab WHO Regional Director for Europe 18 April 2011,
More informationRECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON
RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE 2018 2019 WINTER SEASON October 2018 Address requests about publications of the WHO Regional Office for Europe to: Publications WHO Regional Office for
More informationEuropean Status report on Alcohol and Health
European Status report on Alcohol and Health Dr Lars Moller Regional Advisor a.i. WHO Regional Office for Europe Main killers in the WHO European Region Source: Preventing chronic diseases. A vital investment.
More information26 28 May 2010, Almaty, Kazkhstan. Nina Kerimi UNODC Regional Project Coordinator 1
The 16 th Core Group Meeting of the TB/HIV Working Group 26 28 May 2010, Almaty, Kazkhstan Nina Kerimi UNODC Regional Project Coordinator 1 UNODC Regional Office for Central Asia covers 6 countries: AZE,
More informationA report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10%
% of reported measles cases WHO EpiBrief A report on the epidemiology of selected vaccine-preventable diseases in the European Region No. /17 This issue of WHO EpiBrief provides an overview of selected
More informationHighlighting in the WHO European Region: measles outbreaks rubella surveillance acute flaccid paralysis surveillance
No. 17 (September 2011) A monthly publication on vaccine preventable diseases and immunization data and analysis Issue 15, April 2011 Highlighting in the WHO European Region: measles outbreaks rubella
More informationPriorities for achieving Millennium Development Goals (MDGs) 4 and 5 in the European Region
Priorities for achieving Millennium Development Goals (MDGs) 4 and 5 in the European Region Zsuzsanna Jakab WHO Regional Director for Europe A big challenge Globally every year 7.6 million children die
More informationEastern Europe and Central Asia
Eastern Europe and Central Asia Making the 4Ps Work Prevent infection among adolescents and young people Prevention of mother-to-child transmission Provide paediatric treatment Protection of orphans and
More informationProgress report on the analysis of cancer care
Progress report on the analysis of cancer care by Rie Fujisawa and Vladimir Stevanovic The OECD HCQI Expert Group Meeting Paris, 3 June 2010 1 Progress to date Nomination of cancer experts in 36 countries
More informationDr. Mark R. Dybul Executive Director of the Global Fund to Fight AIDS Tuberculosis and Malaria
Dr. Mark R. Dybul of the Global Fund to Fight AIDS Tuberculosis and Malaria Dear Dr. Dybul, With this letter we, the undersigned organizations representing civil society including organizations representing
More informationWHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA
WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA September 2017 Address requests about publications of the WHO Regional Office for Europe to: Publications WHO Regional Office for Europe Marmorvej
More informationNutrizione nell insufficienza renale cronica; quattro luoghi comuni: il sale, il peso, le proteine e l acqua. Luca Gabutti Bellinzona
Nutrizione nell insufficienza renale cronica; quattro luoghi comuni: il sale, il peso, le proteine e l acqua Luca Gabutti Bellinzona Lose weight! Eat less proteins! Malattia renale cronica e rischio di
More informationProgress in Flour Fortification in Central and Eastern Europe and Commonwealth of Independent States
Progress in Flour Fortification in Central and Eastern Europe and Commonwealth of Independent States Vilma Q. Tyler UNICEF CEE/CIS Regional Nutrition Specialist Ankara, 12-15 June, 2012 Factors Impacting
More informationXDR and MDR TB Urgent Research Priorities. Gerald Friedland MD Yale School of Medicine Nelson R Mandela School of Medicine
XDR and MDR TB Urgent Research Priorities Gerald Friedland MD Yale School of Medicine Nelson R Mandela School of Medicine The Year of MDR XDR TB CDC, WHO report on global XDR TB XDR TB defined Global distribution
More informationSummary. Primary care data. Week 49/2014. Season
Summary Week 49/2014 In week 49/2014, influenza activity remained low across the WHO European Region. Twenty countries reported sporadic influenza activity and nine reported increasing trends in consultations
More informationInequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe
Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe 21st Congress of the European Association of Dental Public Health 1 October 2016 Budapest
More informationAccess to HCV treatment in Europe
Access to HCV treatment in Europe 11 December 2015 EHHC, London Svilen Konov, European AIDS Treatment Group (EATG) Mr Svilen Konov European AIDS Treatment Group (EATG) Speaker Name Svilen Konov COMPETING
More informationViral Hepatitis Burden and Policy Directions in the European Region of WHO
Viral Hepatitis Burden and Policy Directions in the European Region of WHO Dr Nedret Emiroglu WHO Regional Office for Europe Brussels 14-15 October 2010 Global Burden of Chronic Viral Hepatitis 2.7% all
More informationGLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA. The critical need to scale up opioid substitution therapy
GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA The critical need to scale up opioid substitution therapy Craig McClure IAS Executive Director Outline of Presentation 1.
More informationHighlighting in the WHO European Region:
No. 23(April 2012) Issue 15, April 2011 A monthly publication on vaccine preventable diseases and immunization data and analysis Highlighting in the WHO European Region: Update on measles in the European
More informationHIV/AIDS IN EASTERN EUROPE AND CENTRAL ASIA (EECA) Charles Ssonko HIV/TB/Hepatitis Adviser Medecins Sans Frontieres
HIV/AIDS IN EASTERN EUROPE AND CENTRAL ASIA (EECA) Charles Ssonko HIV/TB/Hepatitis Adviser Medecins Sans Frontieres Objectives The Epidemiology of HIV/AIDS in the EECA Region (Trends) o The Burden of HIV/AIDS
More informationMany countries in EECA substantially rely on international funding to tackle HIV and TB, and
To: Mr Taavi Rõivas, Prime Minister of Estonia CC: Mr Jevgeni Ossinovski, Minister of Health and Labor Ms Marina Kaljurand, Minister of Foreign Affairs Mr Margus Tsahkna, Minister for Social Protection
More informationHIV and Hepatitis Prevention Programmes in Eastern Europe Case Example: Georgia
HIV and Hepatitis Prevention Programmes in Eastern Europe Case Example: Georgia Nikoloz Chkhartishvili, MD, MS, PhD Deputy Executive Director for Research Infectious Diseases, AIDS and Clinical Immunology
More informationXDR-TB Extensively Drug-Resistant Tuberculosis. What, Where, How and Action Steps
XDR-TB Extensively Drug-Resistant Tuberculosis What, Where, How and Action Steps The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever
More informationMolecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA
SURVEILLANCE REPORT Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA March 2017 Summary This report describes the geographical and temporal distribution of multidrug-resistant
More informationAccess to ART in Eastern Europe. Andrzej Horban Warsaw Medical University& Hospital of Infectious Diseases
Access to ART in Eastern Europe Andrzej Horban Warsaw Medical University& Hospital of Infectious Diseases WHO Regions Cases per 100 000 population HIV infection in the three geographical areas EU/EEA,
More informationUpdates on the global TB Global TB burden Policy response Treatment approaches
Ernesto Updates on the global TB Global TB burden Policy response Treatment approaches Ernesto Jaramillo WHO Global TB Programmme World Health Organization, Geneva, Tuberculosis is the leading infectious
More informationCHAIR: DR JORGE SAMPAIO, UN SECRETARY-GENERAL'S SPECIAL ENVOY TO STOP TB AND FORMER PRESIDENT OF THE PORTUGUESE REPUBLIC
PROVISIONAL AGENDA WEDNESDAY 1 APRIL 2009 SESSION 1: THE CHALLENGE OF M/XDR-TB: GLOBAL AND NATIONAL LEADERSHIP CHAIR: DR JORGE SAMPAIO, UN SECRETARY-GENERAL'S SPECIAL ENVOY TO STOP TB AND FORMER PRESIDENT
More information2016 EUROPEAN GUIDELINES ON CVD PREVENTION IN CLINICAL PRACTICE
2016 EUROPEAN GUIDELINES ON CVD PREVENTION IN CLINICAL PRACTICE Massimo F Piepoli, MD, PhD, FESC, Piacenza, Italy on behalf of the 6 th Joint Task Force 2 3 Guidelines still based upon the principles of
More informationInequality in injury risks
Inequality in injury risks Rationale Injuries a are a neglected but preventable epidemic and in the 53 countries in the WHO European Region account for nearly 800 000 lives lost annually (equivalent to
More informationMolecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA
Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA January 2016 Summary This report describes the geographical and temporal distribution of multidrug-resistant (MDR) tuberculosis
More informationMedia Release. Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences
Media Release Embargoed 00.01 CET Monday 12 th March 2012 Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences Up to 70 percent of
More informationLessons from the European Health Report: implications for sustainable societies Dr Claudia Stein MD, PhD, FFPH
Lessons from the European Health Report: implications for sustainable societies Dr Claudia Stein MD, PhD, FFPH Director Division of Information, Evidence, Research and Innovation WHO Regional Office for
More informationThe OECD Guidelines on Subjective Well-Being
The OECD Guidelines on Subjective Well-Being Marco Mira d Ercole OECD Statistics Directorate Subjective Well-Being: Its Measurement and Use in Public Policies and Decision-Making in Mexico and Latin America,
More informationHighlighting in the WHO European Region: Summary. No. 21(February 2012)
No. 21(February 2012) Issue 15, April 2011 A monthly publication on vaccine preventable diseases and immunization data and analysis Highlighting in the WHO European Region: Update on measles in the European
More informationEURO POLIO PAGE Data as of 04 October 2005 (Week 38)
World Health Organization Regional Office for Europe EURO POLIO PAGE Data as of 04 October 2005 (Week 38) Vaccine-preventable Diseases and Immunization programme, Division of Technical Support website:
More informationVol. 6, No. 23 Summer 2011
Vol. 6, No. 23 Summer 2011 IN THIS ISSUE: Snapshot Knowledge Hub activities to date, in numbers Knowledge Hub Calendar Find out about training workshops and other upcoming events Knowledge Hub in Review
More informationThe challenge of obesity in the WHO European Region
Fact sheet EURO/13/05 Copenhagen, Bucharest, 12 September 2005 The challenge of obesity in the WHO European Region Obesity poses one of the greatest public health challenges for the 21st century, with
More informationTB 2015 burden, challenges, response. Dr Mario RAVIGLIONE Director
TB 2015 burden, challenges, response Dr Mario RAVIGLIONE Director Addis Ababa, Ethiopia 11-13 November 2015 Overview TB basics TB burden & challenges Response: End TB Strategy DAY 1 What is TB? Definition
More informationNDPHS Expert Group on HIV/AIDS and Associated Infections Progress report 27 October, Chair Dr. Ali Arsalo and ITA Ms Outi Karvonen
NDPHS Expert Group on HIV/AIDS and Associated Infections Progress report 27 October, 2011 Chair Dr. Ali Arsalo and ITA Ms Outi Karvonen NDPHS Goals for the HIV/AIDS & AI Expert Group Goal 2: Prevention
More informationCONCEPT NOTE. Addressing HIV and TB Challenges: from Donor Support to Sustainable Health Systems
CONCEPT NOTE Addressing HIV and TB Challenges: from Donor Support to Sustainable Health Systems Official event in the programme of the Estonian Presidency of the Council of the European Union Co-organised
More informationMultidrug-resistant Tuberculosis - World, Europe, Switzerland
Multidrug-resistant Tuberculosis - World, Europe, Switzerland Magglingen March 23, 2017 peter.helbling@bag.admin.ch Topics Definitions Epidemiology of TB and MDR-TB worldwide Treatment outcome results
More informationTuberculosis: Opportunities and Challenges for Achieving HIV Epidemic Control
Tuberculosis: Opportunities and Challenges for Achieving HIV Epidemic Control Suvanand Sahu Deputy Executive Director Stop TB Partnership Secretariat Tuberculosis TB epidemic is declining very slowly We
More informationNational Innovation Systems Archetypal Analysis
American Journal of Theoretical and Applied Statistics 2018; 7(6): 215-221 http://www.sciencepublishinggroup.com/j/ajtas doi: 10.11648/j.ajtas.20180706.13 ISSN: 2326-8999 (Print); ISSN: 2326-9006 (Online)
More informationStrengthening and aligning diagnosis and treatment of drug-resistant TB in Russian Federation
LOGO Strengthening and aligning diagnosis and treatment of drug-resistant TB in Russian Federation Irina A.Vasilyeva Chief TB Specialist of the Russian Ministry of Health Central TB Research Institute,
More informationOutcomes of Health Systems : Towards the development of indicators of amenable mortality
Outcomes of Health Systems : Towards the development of indicators of amenable mortality Work: Juan G. Gay Presentation: Valérie Paris OECD October 9, 2009 Objectives of the project Explore the potential
More informationWHO Meeting on Strengthening measles and rubella laboratory network in the Russian Federation and Newly Independent States
WHO Meeting on Strengthening measles and rubella laboratory network in the Russian Federation and Newly Independent States 8 10 September 2014 Hammamet, Tunisia MEETING REPORT WHO MEETING ON STRENGTHENING
More informationTotal Market Approach to Improving Family Planning Access in the Republic of Georgia
Total Market Approach to Improving Family Planning Access in the Republic of Georgia Presentation Outline Country context and FP/RH background Key strategies to improve family planning access Accomplishments
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Günther G, Lange C, Alexandru S, et al. Treatment outcomes
More informationMONITORING COMPASSIONATE USE OF NEW DRUGS FOR TUBERCULOSIS
MONITORING COMPASSIONATE USE OF NEW DRUGS FOR TUBERCULOSIS MONITORING COMPASSIONATE USE OF NEW DRUGS FOR TUBERCULOSIS Compassionate Use (CU) programs have been utilized for new cancer and HIV drugs to
More informationAnimal health situation of OIE Member Countries in Europe 1 st semester 2012 (and previous)
Animal health situation of OIE Member Countries in Europe 1 st semester 2012 (and previous) 25 th Conference of the OIE Regional Commission for Europe 17 th to 21 st September 2012, Fleesensee Germany
More informationMultidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area
Rapid communications Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area C Ködmön (csaba.kodmon@ecdc.europa.eu)
More informationMonthly measles and rubella monitoring report
SURVEILLANCE REPORT Monthly measles and rubella monitoring report December 2018 Period covered: 1 November 2017 to 31 October 2018 Introduction This monitoring report is based on measles and rubella data
More information